Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IBRX · against 1,335 other Healthcare companies
Ranked #1,196 of 1,336 · scores higher than 10% of peers
Bars: peers in each 10-point band of the profitability score134 peers with a profitability score of 10–19, including IBRX · Click a bar to see the companies
Mainly because of its return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | IBRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | Not reported | 4.7% | — | — | 33% |
| Operating marginHigher is better · 1,251 reported | -151.9% | 7.1% | 11% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -157.9% | 1.7% | 1% | 33% | |
| Return on equityHigher is better · 1,252 reported | Not reported | 3.2% | — | — | Context only |
| Gross marginHigher is better · 1,394 reported | 99.3% | 45.9% | 97% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 1,196 | 14.5B USD | 10 | 30 | |
| 1,196 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 250M SEK (≈$25M) |
| 10 |
| 44 |
| 1,196 | 126M USD | 10 | 32 |
| 1,196 | 6.2B USD | 10 | 44 |
| 1,196 | 8.8B USD | 10 | 31 |
| 1,196 | 255M USD | 10 | 36 |
| 1,196 | 302M USD | 10 | 42 |
| 1,196 | 3.0B USD | 10 | 11 |
| 1,196 | 504M USD | 10 | 24 |